| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |